Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) hit a new 52-week high during trading on Tuesday . The stock traded as high as $159.13 and last traded at $158.73, with a volume of 788,991 shares trading hands. The stock had previously closed at $156.98.

TMO has been the subject of several research reports. Mizuho lifted their price objective on shares of Thermo Fisher Scientific from $150.00 to $160.00 and gave the company a “buy” rating in a research note on Monday, April 4th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $164.00 price objective for the company in a research note on Tuesday, May 3rd. Morgan Stanley restated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Saturday, April 30th. Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Saturday, April 30th. Finally, Bank of America Corp. reaffirmed a “buy” rating and issued a $163.00 target price on shares of Thermo Fisher Scientific in a research report on Wednesday, May 11th. Two investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $157.25.

The company’s 50 day moving average price is $151.20 and its 200-day moving average price is $142.60. The firm has a market capitalization of $62.52 billion and a P/E ratio of 31.97.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Thursday, April 28th. The company reported $1.80 EPS for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.06. The company had revenue of $4.29 billion for the quarter, compared to analyst estimates of $4.11 billion. The business’s revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.63 EPS. On average, analysts expect that Thermo Fisher Scientific Inc. will post $8.13 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Stockholders of record on Thursday, September 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date is Tuesday, September 13th.

In related news, CAO Peter E. Hornstra sold 7,811 shares of the stock in a transaction that occurred on Monday, May 16th. The stock was sold at an average price of $150.00, for a total transaction of $1,171,650.00. Following the completion of the sale, the chief accounting officer now owns 21,246 shares in the company, valued at approximately $3,186,900. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Marc N. Casper sold 30,000 shares of the stock in a transaction that occurred on Friday, July 1st. The shares were sold at an average price of $148.85, for a total value of $4,465,500.00. Following the sale, the chief executive officer now owns 350,998 shares of the company’s stock, valued at approximately $52,246,052.30. The disclosure for this sale can be found here.

Other hedge funds have made changes to their positions in the company. MUFG Americas increased its stake in shares of Thermo Fisher Scientific by 6.9% in the third quarter. MUFG Americas now owns 26,338 shares of the company’s stock valued at $3,222,000 after buying an additional 1,702 shares during the last quarter. Intermede Investment Partners Ltd acquired a new stake in shares of Thermo Fisher Scientific during the fourth quarter valued at $22,055,000. Sivik Global Healthcare LLC acquired a new stake in shares of Thermo Fisher Scientific during the fourth quarter valued at $4,965,000. Guyasuta Investment Advisors Inc. increased its stake in shares of Thermo Fisher Scientific by 1.1% in the fourth quarter. Guyasuta Investment Advisors Inc. now owns 102,062 shares of the company’s stock valued at $14,477,000 after buying an additional 1,098 shares during the last quarter. Finally, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp increased its stake in shares of Thermo Fisher Scientific by 101.9% in the fourth quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp now owns 53,700 shares of the company’s stock valued at $7,617,000 after buying an additional 27,100 shares during the last quarter.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.